fluoxetine has been researched along with Amyloid Deposits in 4 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cavalli, A | 1 |
Bolognesi, ML | 1 |
Minarini, A | 1 |
Rosini, M | 1 |
Tumiatti, V | 1 |
Recanatini, M | 1 |
Melchiorre, C | 1 |
Zhu, L | 1 |
Ploessl, K | 1 |
Kung, HF | 1 |
Wang, J | 2 |
Zhang, Y | 2 |
Xu, H | 2 |
Zhu, S | 2 |
Wang, H | 2 |
He, J | 1 |
Zhang, H | 1 |
Guo, H | 2 |
Kong, J | 2 |
Huang, Q | 2 |
Li, XM | 2 |
Qiao, J | 1 |
Adilijiang, A | 1 |
Zhang, R | 1 |
Guo, W | 1 |
Luo, G | 1 |
Qiu, Y | 1 |
1 review available for fluoxetine and Amyloid Deposits
Article | Year |
---|---|
Multi-target-directed ligands to combat neurodegenerative diseases.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium | 2008 |
3 other studies available for fluoxetine and Amyloid Deposits
Article | Year |
---|---|
Chemistry. Expanding the scope of fluorine tags for PET imaging.
Topics: Alzheimer Disease; Aniline Compounds; Celecoxib; Ethylene Glycols; Fluorescent Dyes; Fluorine Radioi | 2013 |
Fluoxetine improves behavioral performance by suppressing the production of soluble β-amyloid in APP/PS1 mice.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Disease Models, Animal; Emotions; | 2014 |
Regulation of astrocyte pathology by fluoxetine prevents the deterioration of Alzheimer phenotypes in an APP/PS1 mouse model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Astrocytes; Brain | 2016 |